CNDSN3 month 3 days [] (the wisdom of the great financial) Kangmei Pharmaceutical (600518.SH) under the medicinal trade platform in E bulk Trough since this year trading sharply peatlands growth, the daily turnoverof over 1000000000 yuan, capital market speculation triggered enthusiasm. Great wisdom, big data terminal display, since February, the company's share price has risen by over 40%.

A large domestic medicine market price information market site general manager of the great wisdom ofNews Agency (DZH_NEWS) said, promising Kangmei pharmaceutical mode, by constructing the futures market to solve their own raw material supply problems, e trough is a new traditional Chinese medicinebusiness, and traditional Chinese medicine raw materials procurement bidding mode of the traditionaldispersion compared to the more progress. But he also pointed out that, Kangmei pharmaceutical itself asChinese medicinal materials suppliers, the influence degree of futures market to provide to the industryremains to be seen. "Futures trading is best by platform oriented enterprises to build, such as Tongrentangwill not to Kang beauty futures market trading."

Public data shows, e trough to put into operation in 2012 December, is a Chinese herbal medicine bulk trading platform centralized drug information service, traditional Chinese medicinal materials of electronictrading and settlement services for the whole. At present, e trough monthly transaction volume of over 20000000000, of which the physical delivery of about 2000000000.

Guoxin Securities research report pointed out, e trough "physical delivery + virtual transactions" patterngradually mature will enable the company to have the pricing power of Chinese herbal medicines. The company trade business model will gradually from the traditional traders gradually turned into traditional Chinese medicine market maker, Chinese herbal medicine circulation industry supply chain service provider of integrated, trade business valuation system to reconstruct. "The Chinese herbal medicine spot tradingvolume reached 200000000000, if the development of electronic trading and futures market, trading volumeis likely to exceed trillion."

Kangmei pharmaceutical industry is the domestic Chinese medicine industry chain leading enterprises. In 2013 the company achieved operating income of 13400000000, net profit attributable to shareholders of the listing Corporation 1880000000. *

(original title: Kang beauty of Chinese herbal medicines Trading Platform trading volume sought after shares rose)

Editor: Blue